| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.11 | 0.1 |